MoneyWorks4Me

The Turnover for the quarter ended September 2024 of Rs. 1014.92 millions increase by 62.68% from Rs. 623.87 millions.Net profit surges 76.47% to Rs. 109.50  millions  from Rs. 62.05 millions in the quarter ended September 2024.Operating profit for the quarter ended September 2024 rose to 161.13 millions as compared to 100.95 millions of corresponding quarter ended September 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 1014.92 623.87 62.68 1883.23 1217.51 54.68 2583.60 2246.44 15.01
Other Income 41.84 40.04 4.50 54.97 58.81 -6.53 131.01 146.10 -10.33
PBIDT 161.13 100.95 59.61 278.97 181.31 53.86 409.55 342.22 19.67
Interest 1.62 10.76 -84.94 5.48 21.98 -75.07 44.49 31.30 42.14
PBDT 159.49 90.19 76.84 273.47 159.33 71.64 364.82 311.05 17.29
Depreciation 13.00 8.79 47.90 26.00 19.79 31.38 47.22 45.39 4.03
PBT 146.49 81.40 79.96 247.47 139.54 77.35 317.60 265.66 19.55
TAX 36.99 19.35 91.16 61.68 35.00 76.23 81.36 64.95 25.27
Deferred Tax 2.13 4.51 -52.77 2.44 4.13 -40.92 5.54 -1.53 -462.09
PAT 109.50 62.05 76.47 185.79 104.54 77.72 236.24 200.71 17.70
Equity 940.00 940.00 0.00 940.00 940.00 0.00 940.00 940.00 0.00
PBIDTM(%) 15.88 16.18 -1.89 14.81 14.89 -0.53 15.85 15.23 4.06
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..